Synapse - Larry Norton

Search Within

Larry Norton

Results (200)

A combined analysis of outcome following breast cancer: differences in survival based on BRCA1/BRCA2 mutation status and administration of adjuvant treatment

Journal Article

Robson, M. E.; Chappuis, P. O.; Satagopan, J.; Wong, N.; Boyd, J.; Goffin, J. R.; Hudis, C.; Roberge, D.; Norton, L.; Begin, L. R.; more...
Breast Cancer Research (2003)

Fulltext@MSK | Save

Effects of exemestane and raloxifene on breast density by mammography and MRI in postmenopausal women: Preliminary data from a pilot chemoprevention trial

Meeting Abstract

Dickler, M.; Morris, E.; Robson, M.; Choi, J.; Hummer, A.; Panageas, K.; Ballon, D.; Borgen, P.; Norton, L.; Hudis, C.
Cancer Epidemiology Biomarkers and Prevention (2002)

Fulltext@MSK | Save

Effect of creatinine clearance (CrCl) on patterns of toxicity in breast cancer (BC) patients (pts) age 65 and older receiving adjuvant chemotherapy

Meeting Abstract

Hurria, A.; Panageas, K.; Brogan, K.; Norton, L.; Howard, J.; Hudis, C.
Breast Cancer Research and Treatment (2002)

Fulltext@MSK | Save

Serum HER2 extracellular domain (ECD) correlates with HER2 status by immunohistochemistry (IHC) and fluorescent in-situ hybridization (FISH) in metastatic breast cancer (MBC) patients (pts) treated with weekly (W) trastuzumab (H) and paclitaxel (T)

Meeting Abstract

Fornier, M. N.; Seidman, A. D.; Schwartz, M. K.; Panageas, K. S.; Norton, L.; Hudis, C. A.
Breast Cancer Research and Treatment (2002)

Fulltext@MSK | Save

Assessment of molecular markers of clinical sensitivity to single-agent taxane therapy for metastatic breast cancer

Journal Article

Van Poznak, C.; Tan, L.; Panageas, K. S.; Arroyo, C. D.; Hudis, C.; Norton, L.; Seidman, A. D.
Journal of Clinical Oncology (2002)

Fulltext@MSK | Save

Outcome of preventive surgery and screening for breast and ovarian cancer in BRCA mutation carriers

Journal Article

Scheuer, L.; Kauff, N.; Robson, M.; Kelly, B.; Barakat, R.; Satagopan, J.; Ellis, N.; Hensley, M.; Boyd, J.; Borgen, P.; more...
Journal of Clinical Oncology (2002)

Fulltext@MSK | Save

Prospective exploratory analysis of the association between tumor response, quality of life, and expenditures among patients receiving paclitaxel monotherapy for refractory metastatic breast cancer

Journal Article

Modi, S.; Panageas, K. S.; Duck, E. T.; Bach, A.; Weinstock, N.; Dougherty, J.; Cramer, L.; Hudis, C.; Norton, L.; Seidman, A.
Journal of Clinical Oncology (2002)

Fulltext@MSK | Save

Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation

Journal Article

Kauff, N. D.; Satagopan, J. M.; Robson, M. E.; Scheuer, L.; Hensley, M.; Hudis, C. A.; Ellis, N. A.; Boyd, J.; Borgen, P. I.; Barakat, R. R.; more...
New England Journal of Medicine (2002)

Fulltext@MSK | Save

Immunization of metastatic breast cancer patients with a fully synthetic globo H conjugate: A phase I trial

Journal Article

Gilewski, T.; Ragupathi, G.; Bhuta, S.; Williams, L. J.; Musselli, C.; Zhang, X. F.; Bencsath, K. P.; Panageas, K. S.; Chin, J.; Hudis, C. A.; more...
Proceedings of the National Academy of Sciences of the United States of America (2001)

Fulltext@MSK | Save

Weekly trastuzumab and paclitaxel therapy for metastatic breast cancer with analysis of efficacy by HER2 immunophenotype and gene amplification

Journal Article

Seidman, A. D.; Fornier, M. N.; Esteva, F. J.; Tan, L.; Kaptain, S.; Bach, A.; Panageas, K. S.; Arroyo, C.; Valero, V.; Currie, V.; more...
Journal of Clinical Oncology (2001)

Fulltext@MSK | Save